IADR Abstract Archives

Amelogenesis Imperfecta in Patients With Hypercalcemia Due to GNA11 Mutations

Objectives: In this study, we aimed to determine whether Familial Hypercalcemia Hypocalciuria 2 (FHH2) is a cause of Amelogensis Imperfecta (AI).
Methods: Dental examination of patients with FHH2
We diagnosed hypomineralized amelogenesis imperfecta in the affected individuals of two unrelated families with FHH2. This manifested by high susceptibility to caries and enamel wear.

Dental tissue studies of FHH2 teeth
First, we collected and prepared deciduous teeth from 2 FHH2 patients and age-matched controls. We performed several techniques to study the microanatomy of the dental tissues (SEM, Synchrotron beam ID19 , EDS, Raman micro-spectroscopy). Second, we studied the expression of GNA11/Gna11 in the human and mouse tooth germ via scRNAseq atlas. Third, we investigated more in depth the expression of Gna11/Gα11 in the mouse tooth germ (RT-qPCR, RNA Scope, Western blot, immunohistochemistry).
Results: SEM analysis showed slightly more “tapered” enamel prisms in FHH2 teeth and abnormal dentin. EDS showed a significant difference in mineralization of both enamel and dentin (lower Ca/P ratio for both tissues in the FHH2 teeth compared to control). Synchrotron acquisitions revealed punctual patches of demineralization following no set pattern in the FHH2 enamel.

Single-cell transcriptome atlas analysis of human and murine tooth germ revealed that GNA11/Gna11 was expressed at all stages of amelogenesis. We performed RT-qPCR and western blot analyses on molar and incisor germs from WT mice, showing robust Gna11/Gα11 expression. We next performed RNA Scope and immunofluorescence on OCT-included frontal and sagittal postnatal tooth germ sections. We found Gna11/Gα11 expression in both ameloblasts and odontoblasts.
Conclusions: This study shows that variants in GNA11 responsible for hypercalcemia, are a novel cause of AI. Multiproxy analyses of primary teeth affected by FHH2 revealed abnormal mineralization of enamel and dentin. In addition, combined molecular and protein analyses confirmed the expression of Gna11/Gα11 in the murine tooth germ, in both ameloblasts and odontoblasts.
Division:
Meeting: 2025 IADR/PER General Session & Exhibition (Barcelona, Spain)
Location: Barcelona, Spain
Year: 2025
Final Presentation ID: 0566
Abstract Category|Abstract Category(s): Mineralized Tissue
Authors
  • Obtel, Nicolas  ( Université Paris Cité, UMR1333 Santé Orale, INSERM et Plateforme Imagerie du Vivant (PIV), FHU-DDS-net, Dental School , Montrouge , France ;  AP-HP Services de médecine bucco-dentaire, Hôpitaux Universitaires Bretonneau (CRMR phosphore et calcium, filière OSCAR et ERN Bond), Charles Foix, and Henri Mondor (CRMR ORares, filière TeteCou, ERN Cranio) ; FHU DDS-net , Ile de France , France )
  • Hannan, Fadil  ( Larsson-Rosenquist Foundation Oxford Centre for the Endocrinology of Human Lactation, Nuffield Department of Women's & Reproductive Health, University of Oxford , Oxford , United Kingdom )
  • Coradin, Thibaud  ( Sorbonne Université, CNRS, Laboratoire de Chimie de la Matière Condensée de Paris , Paris , France )
  • Thakker, Rajesh  ( Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford , Oxford , United Kingdom ;  National Institute for Health Research Oxford Biomedical Research Centre , Oxford , United Kingdom ;  Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London , London , United Kingdom )
  • Bertocchio, Jean-philippe  ( Service Thyroïde -Tumeurs Endocrines, Hôpital de la Pitié-Salpêtrière, Assistance Publique – Hôpitaux de Paris, Paris, France (CCMR maladies rares du calcium et du phosphate, rare disease network OSCAR) , Paris , France )
  • Chaussain, Catherine  ( Université Paris Cité, UMR1333 Santé Orale, INSERM et Plateforme Imagerie du Vivant (PIV), FHU-DDS-net, Dental School , Montrouge , France ;  AP-HP Services de médecine bucco-dentaire, Hôpitaux Universitaires Bretonneau (CRMR phosphore et calcium, filière OSCAR et ERN Bond), Charles Foix, and Henri Mondor (CRMR ORares, filière TeteCou, ERN Cranio) ; FHU DDS-net , Ile de France , France )
  • Le Cabec, Adeline  ( Univ. Bordeaux, CNRS, Ministère de la Culture, PACEA, UMR 5199 , Pessac , France )
  • Hermans, Florian  ( Department of Cardiology and Organ Systems (COS), Biomedical Research Institute (BIOMED), Faculty of Medicine and Life Sciences, Hasselt University, 3590 , Diepenbeek , Belgium )
  • Attia, Amina  ( Service Thyroïde -Tumeurs Endocrines, Hôpital de la Pitié-Salpêtrière, Assistance Publique – Hôpitaux de Paris, Paris, France (CCMR maladies rares du calcium et du phosphate, rare disease network OSCAR) , Paris , France )
  • Chansavang, Albain  ( Université Paris Cité, APHP, Département de Médecine Génomique des Tumeurs et Cancers, site Cochin, Paris, FranceUniversité Paris Cité, APHP, Département de Médecine Génomique des Tumeurs et Cancers, site Cochin , Paris , France ;  Institut Cochin, Inserm U1016, CNRS UMR8104, Université Paris Cité, CARPEM , Paris , France )
  • Lakhel, Anne Laure  ( Université Paris Cité, UMR1333 Santé Orale, INSERM et Plateforme Imagerie du Vivant (PIV), FHU-DDS-net, Dental School , Montrouge , France ;  AP-HP Services de médecine bucco-dentaire, Hôpitaux Universitaires Bretonneau (CRMR phosphore et calcium, filière OSCAR et ERN Bond), Charles Foix, and Henri Mondor (CRMR ORares, filière TeteCou, ERN Cranio) ; FHU DDS-net , Ile de France , France )
  • Linglart, Agnès  ( Paris-Saclay University, AP-HP, INSERM, Department of Endocrinology and Diabetes for Children, Unité Physiologie et physiopathologie endocrinienne - U1185, Bicêtre Paris Saclay Hospital, 64 Gabriel Péri Street, 94270 , France. , Le Kremlin Bicêtre , France )
  • Pasmant, Eric  ( Institut Cochin, Inserm U1016, CNRS UMR8104, Université Paris Cité, CARPEM , Paris , France )
  • Ramirez Rozzi, Fernando  ( UMR 7206 CNRS MNHN UP Eco-anthropologie Musée de l’Homme , Paris , France ;  Université Paris Cité, UMR1333 Santé Orale, INSERM et Plateforme Imagerie du Vivant (PIV), FHU-DDS-net, Dental School , Montrouge , France )
  • Financial Interest Disclosure: NONE
    SESSION INFORMATION
    Poster Session
    Mineralized Tissue I
    Thursday, 06/26/2025 , 11:00AM - 12:15PM